Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen
Condition(s):Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic SyndromesLast Updated:July 17, 2017Completed